Nelson, David S <br/><br/>
MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis.  [electronic resource] 

 -  Genes, chromosomes & cancer  Jun 2015 
 - 361-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-2264 
<br/><br/><label>Standard No.: </label>10.1002/gcc.22247  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Histiocytosis, Langerhans-Cell--genetics<br/>Humans<br/>MAP Kinase Kinase 1--genetics<br/>MAP Kinase Kinase Kinase 1--genetics<br/>Mutation<br/>Phosphorylation--drug effects<br/>Pyridones--pharmacology<br/>Pyrimidinones--pharmacology<br/>Signal Transduction